American Green Inc (OTCMKTS:ERBB) has closed the establishment of a joint venture deal with Hempful Farms, Inc. This deal will permit the firm to market and offer ‘Paw Puddy pet line of Cannabinoid products in company’s web store found at www.americangreencbd.com and accessible on that site in the imminent few days.
The line, commenced four years earlier as an ointment for dog’s paws is now accessible in 27 dispensaries in Arizona and three of the leading dispensaries in Colorado and in Hempful Farms web outlet at www.hempfulfarms.com. Prospects to move into an equestrian line, something company pursued for some time, and the opportunity to associate with Hempful Farms’ other offerings are all things American Green intends to pursue.
Chris Martin, who developed Hempful Farms, built a firm committed to manufacturing hemp products made of just the best ingredients accessible after he and his family noted improvements to health from the use of Cannabinoid products. Cannabidiol has wide potential and growing recognition as a medicinal treatment.
In May, the New England Journal of Medicine released report from a peer-assessed double-blind placebo-controlled study demonstrating successful application in the cure of Dravet Syndrome, a grave childhood epilepsy disorder that is related with drug-resistant seizures as well as a high mortality rate. Unlike THC seen in marijuana, Cannabinoid does not result in the psychoactive effects that can result in the high one experiences when taken for that specific purpose.
Martin’s rottweiler, Sarge, was identified with hip dysplasia that made him to limp. Without anticipation for another therapy, Martin had the notion of curing Sarge’s problem with the same cannabinoid offerings he was using. The promising data resulted in the birth of Paw Puddy, an offering planned toward helping pets.
Andrea and Chris Martin have been developing their hemp-infused Paw Puddy offerings in limited space; but the popularity of their offerings commands they expand their facilities straightway in order to match demand. Hempful Farms’ deal with American Green will achieve that objective.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of financialstrend.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: